CholecystolithiasisNCT07854379
A Survey of Public Attitudes Towards Gallbladder-preserving Lithotomy and Its Influencing Factors
An observational study of Cholecystolithiasis, run by Changzhou No.2 People's Hospital at 1 site in China.
Trial summary
This study aims to understand public/patient attitudes toward gallbladder preservation surgery by means of questionnaires, and hopes to achieve the following objectives: 1. To understand public/patient attitudes towards gallbladder preservation surgery and provide new evidence for the controversy over gallbladder… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cholecystolithiasis
- How many people
- 5,000 participants
- Where
- 1 siteChina
- Study dates
- 21 Jul 2026to 30 Apr 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The general public without medical or nursing background
Who may be able to join
- Conscious and able to complete the questionnaire independently
- Voluntary participation in this study and signing of informed consent
Who cannot join
- Refusal to participate in this study
- Inability to participate in this study due to mental illness, cognitive impairment, or other insurmountable reasons such as visual or hearing impairment
- People with medical or nursing backgrounds
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
The Second People's Hospital of Changzhou
Changzhou, Jiangsu, 213000
051988104931
About this study
This study aims to understand public/patient attitudes toward gallbladder preservation surgery by means of questionnaires, and hopes to achieve the following objectives:
- To understand public/patient attitudes towards gallbladder preservation surgery and provide new evidence for the controversy over gallbladder preservation surgery;
- Introduce a new kind of "evidence" into this controversy: social or preference evidence；
- Verify the applicability of informed choice and shared decision making；
- Provide "public opinion" reference for medical policy and guideline formulation ，and help them develop guidelines or policies that are more in line with patients 'needs；
- Help clinicians understand patients 'concerns, provide basis for making more scientific individualized treatment decisions, and promote the standardization process of diagnosis and treatment of benign gallbladder diseases.
The survey will be conducted in the Second People's Hospital of Changzhou City from July 2026 to December 2026 in the form of questionnaire (electronic questionnaire). The questionnaire will be distributed to all regions of the Chinese mainland, and will be conducted daily by in-hospital doctors and designated questionnaire collectors.
Read the detailed description
Gallbladder benign disease is a common digestive system disease among adults in China, and its incidence is on the rise worldwide. Cholecystectomy has become the standard procedure for benign gallbladder disease since 1882 because of its strong curative effect and low recurrence rate. However, many complications or adverse reactions may occur after gallbladder loss, such as diarrhea and dyspepsia. With the improvement of people's requirements for quality of life and the penetration of the concept of "precision medicine","gallbladder-preserving lithotomy" has been carried out to a certain extent in clinical practice. However, most experts and scholars in hepatobiliary surgery oppose "gallbladder-preserving lithotomy", believing that there are problems such as high recurrence rate of gallstones after gallbladder-preserving surgery and irregular surgical methods.
There has been considerable controversy over this procedure for a long time. However, there is no high-quality supporting evidence for and against it, and the current evidence is insufficient to deny the rationality of "gallbladder preservation" surgery. For the gallbladder preservation controversy, the existing evidence focuses on medical factors such as clinical treatment results and professional opinions, while a key non-medical factor-public/patient attitude-has been largely ignored. Therefore, we intend to understand the public/patient attitude towards gallbladder preservation surgery through questionnaires, and provide new evidence for the current controversy over gallbladder preservation surgery.
- Conditions
- Cholecystolithiasis
- Medical subject headings
- Cholecystolithiasis
What is being measured
The primary outcome is the main question the study is designed to answer.
Public attitude towards gallbladder-preservation surgery
Three types of attitudes: support, neutral, oppose
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2026
- Study start21 Jul 2026
- Primary completion28 Feb 2027 (estimated)
- Study completion30 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CholecystolithiasisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 5,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Changzhou No.2 People's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, luokai zhang, Changzhou No.2 People's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07854379
- Sponsor's protocol ID
- QGBP2026
- Status last verified
- Sep 2026
- First submitted
- 20 Sep 2026
- Last updated
- 2 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Survey of Public Attitudes Towards Gallbladder-preserving Lithotomy and Its Influencing Factors
- ClinicalTrials.gov ID
- NCT07854379
- Acronym / sponsor ID
- QGBP2026
- Conditions
- Cholecystolithiasis
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 5,000 participants (estimated)
- Lead sponsor
- Changzhou No.2 People's HospitalUniversity, hospital or other
- Study start
- 21 Jul 2026 (actual)
- Primary completion
- 28 Feb 2027 (estimated)
- Study completion
- 30 Apr 2027 (estimated)
- First posted
- 2 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to understand public/patient attitudes toward gallbladder preservation surgery by means of questionnaires, and hopes to achieve the following objectives:
- To understand public/patient attitudes towards gallbladder preservation surgery and provide new evidence for the controversy over gallbladder preservation surgery;
- Introduce a new kind of "evidence" into this controversy: social or preference evidence；
- Verify the applicability of informed choice and shared decision making；
- Provide "public opinion" reference for medical policy and guideline formulation ，and help them develop guidelines or policies that are more in line with patients 'needs；
- Help clinicians understand patients 'concerns, provide basis for making more scientific individualized treatment decisions, and promote the standardization process of diagnosis and treatment of benign gallbladder diseases.
The survey will be conducted in the Second People's Hospital of Changzhou City from July 2026 to December 2026 in the form of questionnaire (electronic questionnaire). The questionnaire will be distributed to all regions of the Chinese mainland, and will be conducted daily by in-hospital doctors and designated questionnaire collectors.
Detailed description
Gallbladder benign disease is a common digestive system disease among adults in China, and its incidence is on the rise worldwide. Cholecystectomy has become the standard procedure for benign gallbladder disease since 1882 because of its strong curative effect and low recurrence rate. However, many complications or adverse reactions may occur after gallbladder loss, such as diarrhea and dyspepsia. With the improvement of people's requirements for quality of life and the penetration of the concept of "precision medicine","gallbladder-preserving lithotomy" has been carried out to a certain extent in clinical practice. However, most experts and scholars in hepatobiliary surgery oppose "gallbladder-preserving lithotomy", believing that there are problems such as high recurrence rate of gallstones after gallbladder-preserving surgery and irregular surgical methods.
There has been considerable controversy over this procedure for a long time. However, there is no high-quality supporting evidence for and against it, and the current evidence is insufficient to deny the rationality of "gallbladder preservation" surgery. For the gallbladder preservation controversy, the existing evidence focuses on medical factors such as clinical treatment results and professional opinions, while a key non-medical factor-public/patient attitude-has been largely ignored. Therefore, we intend to understand the public/patient attitude towards gallbladder preservation surgery through questionnaires, and provide new evidence for the current controversy over gallbladder preservation surgery.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The general public without medical or nursing background
Key inclusion criteria (2 listed)
- Conscious and able to complete the questionnaire independently
- Voluntary participation in this study and signing of informed consent
Key exclusion criteria (3 listed)
- Refusal to participate in this study
- Inability to participate in this study due to mental illness, cognitive impairment, or other insurmountable reasons such as visual or hearing impairment
- People with medical or nursing backgrounds
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Public attitude towards gallbladder-preservation surgery
Time frame: 1 year
Three types of attitudes: support, neutral, oppose
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Cholecystolithiasis
Not yet recruitingPhase 4
Effect of Prophylactic Dexamethasone vs Placebo on Airway Dimensions Assessed by Ultrasonography in Patients Undergoing Laparoscopic Cholecystectomy
Airway Edema, Postoperative Complications
Not yet recruiting
Two Bupivacaine Concentrations for Recto-Intercostal Fascial Plane Block After Laparoscopic Cholecystectomy
Postoperative Pain, Acute Pain
Active, not recruiting
Comparison of the Efficacy of Different Analgesic Strategies for Pain Control After Laparoscopic Cholecystectomy (LC)
Gallstones, Pain
RecruitingObservational study
Electrosurgical Patterns and Learning Curve in Elective Laparoscopic Cholecystectomy
Cholelithiasis
Recruiting
Timing of CHolecystectomy In Severe PAncreatitis
Acute Pancreatitis, Cholelithiasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cholecystolithiasis, run by Changzhou No.2 People's Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chunfu Zhu, MD (13961190702, zcfmlm@njmu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Public attitude towards gallbladder-preservation surgery (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.